kras mutation and glutathion The roles of in cancer metabolism, tumor microenvironment clinical therapy | Molecular Cancer KRAS G12D: The Next Frontier
KRAS G12D: The Next Frontier in Cancer Therapy MedChemExpress Targeting KRAS Mutant Cancers with a Covalent G12C Specific Inhibitor: Cell Frontiers KRAS mutation: The booster of pancreatic ductal adenocarcinoma transformation and progression KRAS OriGene Technologies Inc.
Pay in 4 interest-free payments of $6.36 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18



